← Back to Search

Contact Lens

Contact Lenses for Vision Correction

N/A
Waitlist Available
Led By Carolyn MacNeil
Research Sponsored by Coopervision, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Is at least 18 years of age and no older than 39 years, and has full legal capacity to volunteer
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 27
Awards & highlights

Study Summary

This trial compares the effectiveness of two different contact lenses to improve vision in people who wear contacts regularly.

Who is the study for?
This trial is for people aged 18-39 who wear soft contact lenses, have had a full eye exam in the last two years, and can commit to wearing the test lenses at least 8 hours daily. Participants should be free of eye diseases or conditions that make lens-wearing unsafe and not be on any conflicting medications.Check my eligibility
What is being tested?
The study compares two types of monthly replacement contact lenses: Lens B (lotrafilcon B) and Lens A (fanfilcon A). Habitual soft lens users will switch to these test lenses to evaluate their performance over one month.See study design
What are the potential side effects?
While specific side effects are not listed, typical risks with contact lens use include eye irritation, dryness, redness, reduced vision quality, infection risk increase if hygiene practices aren't followed.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 39 years old and can legally consent.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 27
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 27 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Lens Handling on Removal

Trial Design

2Treatment groups
Experimental Treatment
Group I: Lens B, then Lens AExperimental Treatment2 Interventions
Participants will wear Lens B one month and then wear Lens A for one month.
Group II: Lens A, then Lens BExperimental Treatment2 Interventions
Participants will wear Lens A for one month and then wear Lens B for one month.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Lens A (fanfilcon A)
2021
N/A
~40

Find a Location

Who is running the clinical trial?

COREUNKNOWN
10 Previous Clinical Trials
2,250 Total Patients Enrolled
Coopervision, Inc.Lead Sponsor
155 Previous Clinical Trials
13,784 Total Patients Enrolled
Centre for Ocular Research & Education, CanadaOTHER
10 Previous Clinical Trials
2,250 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the age criterion for this trial include participants aged 50 or above?

"This clinical trial is seeking participants between the ages of 18 and 39."

Answered by AI

Who could be suitable candidates for this experiment?

"Potential participants must have farsightedness and be between 18-39 years of age to qualify for this trial. 45 individuals will ultimately partake in the study."

Answered by AI

Is this trial currently available to those seeking treatment?

"As evidenced by clinicaltrials.gov, this research project is no longer recruiting participants. This trial first appeared on November 1st2023 and was last modified on October 19th2023. Notwithstanding, there are presently 126 other studies actively searching for suitable volunteers."

Answered by AI
~30 spots leftby Apr 2025